Filtered By:
Specialty: OBGYN

This page shows you your search results in order of date. This is page number 8.

Order by Relevance | Date

Total 345 results found since Jan 2013.

Systolic Hypertension, Preeclampsia-Related Mortality, and Stroke In California.
PMID: 31568350 [PubMed - in process]
Source: Obstetrics and Gynecology - September 30, 2019 Category: OBGYN Authors: Messerli FH, Raio L, Baumann M, Rimoldi S, Rexhaj E Tags: Obstet Gynecol Source Type: research

Personality traits and the risk of coronary heart disease or stroke in women with diabetes – an epidemiological study based on the Women's Health Initiative
Conclusions: Hostility was associated with incidence of CHD among postmenopausal women with diabetes, especially among incident diabetes. These results provide a basis for targeted prevention programs for women with a high level of hostility and diabetes.
Source: Menopause - September 28, 2019 Category: OBGYN Tags: Original Articles Source Type: research

Neurological disease in pregnancy
Neurological disease encompasses a broad spectrum of conditions which may be affected by pregnancy, present de novo in pregnancy, or are caused by the pregnancy itself. In the UK, 9.8 women in 100,000 died during pregnancy or up to 42 days after delivery (Mothers and Babies Reducing Risk through Confidential Enquiry (MBRRACE) report 2018). Neurological diseases, including epilepsy and stroke, continues to be the second leading indirect cause of maternal mortality and the numbers have not changed since reporting began in 1985, despite the availability of easily accessible Green-top Guidelines on the management of epilepsy t...
Source: Obstetrics, Gynaecology and Reproductive Medicine - September 16, 2019 Category: OBGYN Authors: Felicity Coad, Catherine Nelson –Piercy Tags: Review Source Type: research

Increased suicide risk among patients oophorectomized following benign conditions and its association with comorbidities.
Conclusion: A significant increase in suicide rate among oophorectomized women aged 20-49 years was found. The decision to perform oophorectomy should be made cautiously, especially in patients with hypertension, COPD, chronic liver disease and cirrhosis or anxiety disorder. Patients should be followed for at least 6 years postoperatively since the suicide rate is significantly higher in this period. PMID: 31462149 [PubMed - as supplied by publisher]
Source: Journal of Psychosomatic Obstetrics and Gynaecology - August 31, 2019 Category: OBGYN Tags: J Psychosom Obstet Gynaecol Source Type: research

Hysterectomy for men – Richard ’ s story
My wife (now 65) has had a number of minor medical problems, both mental and physical, especially after reaching 40, and when she started having panic attacks, for which no-one could provide a positive reason or cure, she finally resorted to drugs, such as sertraline, much against her natural inclination. A known side-effect of this is increased weight.  My wife has never been really overweight, but, in common with so many women, is very sensitive about the subject (perhaps more so because I CANNOT put on weight!), so when she started to increase in girth, I was reluctant to mention it, for fear of upsetting her even more...
Source: The Hysterectomy Association - August 3, 2019 Category: OBGYN Authors: Linda Parkinson-Hardman Tags: Health hysterectomy stories ovarian cyst Source Type: news

Women's Health Initiative clinical trials: potential interactive effect of calcium and vitamin D supplementation with hormonal therapy on cardiovascular disease
Conclusions: CaD did not consistently modify the effect of CEE therapy or CEE + MPA therapy on CVD events. However, the increased risk of stroke due to CEE therapy appears to be mitigated by CaD supplementation. In contrast, CaD supplementation did not influence the risk of stroke due to CEE + MPA.
Source: Menopause - August 1, 2019 Category: OBGYN Tags: Original Articles Source Type: research

Preventing Fatal Maternal Stroke and Other CV Events Preventing Fatal Maternal Stroke and Other CV Events
Tragic maternal complications can be prevented with closer attention to blood pressure and other CV risk factors.Medscape Ob/Gyn
Source: Medscape ObGyn and Womens Health Headlines - July 25, 2019 Category: OBGYN Tags: Ob/Gyn & Women ' s Health Commentary Source Type: news

Review of Migraine Incidence and Management in Obstetrics and Gynaecology
ConclusionMigraines have a high incidence in gynaecology and obstetrics. Health care providers must include screening questions when history taking to identify women with migraines and effectively manage them. Proper follow-up and treatment is required for all women with migraines in order to minimize the risk of cerebrovascular events, and negative pregnancy outcomes. Women with migraines are advised to avoid combined hormonal contraception and use progesterone only pills.
Source: European Journal of Obstetrics and Gynecology and Reproductive Biology - July 18, 2019 Category: OBGYN Source Type: research

Multicenter, phase III trials on the contraceptive efficacy, tolerability and safety of a new drospirenone only pill
ConclusionsThis is the first report of a new drospirenone only oral contraceptive providing clinical efficacy like combined oral contraceptives, with a good safety profile, and favourable cycle control.This article is protected by copyright. All rights reserved.
Source: Acta Obstetricia et Gynecologica Scandinavica - July 17, 2019 Category: OBGYN Authors: Santiago Palacios, Enrico Colli, Pedro ‐Antonio Regidor Tags: Original Research Article Source Type: research

Age at menarche and risk of all-cause and cardiovascular mortality: a systematic review and dose–response meta-analysis
Conclusions: Age at menarche is inversely associated with all-cause and IHD mortality.
Source: Menopause - June 1, 2019 Category: OBGYN Tags: Original Articles Source Type: research

Vaginal estrogen use and chronic disease risk in the Nurses’ Health Study
Conclusions: Vaginal estrogen use was not associated with a higher risk of cardiovascular disease or cancer. Our findings lend support to the safety of vaginal estrogen use, a highly effective treatment for genitourinary syndrome of menopause.
Source: Menopause - June 1, 2019 Category: OBGYN Tags: Original Articles Source Type: research